It’s raining resignations_Part 2

This time it’s an Aurobindo CEO. Drug firm Aurobindo Pharma said its Chief Executive Officer (Formulations) Arvind Vasudeva has resigned from the company.

Recently, the drug firm had said that it intends to invest up to Rs 900 crore this fiscal on various activities including capacity expansion, clinical trials and product filings.


The company has presence in semi-synthetic penicillins and other key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins among others.

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

WhatsApp Group for Pharma Literati